Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HLTRF

HLS Therapeutics Inc.

USD

Set alert

Price alert · HLTRF

All alert types
3.24 USD +0.05 +1.49%
As of Oct 29, 2026
3.24 Day range 3.25
2.64 52-week range 4.02
YTD
-5.42%
1 year
-19.30%
Open
3.25
Prev close
3.20
Mkt cap
100.35M
Vol
900
Avg vol
632
EPS
-0.27
P/E
0.00
More statistics
Low
3.24
High
3.25

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for HLTRF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -8.6×
FY 2016: -51.3×FY 2017: -7.8×FY 2018: -12.6×FY 2019: -28.3×FY 2020: -28.8×FY 2021: -28.1×FY 2022: -9.9×FY 2023: -4.5×FY 2024: -4.3×FY 2025: -8.6×
FY 2016 5y median -8.6× FY 2025
P/S 1.9×
FY 2016: 0.8×FY 2017: 0.6×FY 2018: 5.1×FY 2019: 10.3×FY 2020: 7.8×FY 2021: 6.2×FY 2022: 3.8×FY 2023: 2.0×FY 2024: 1.5×FY 2025: 1.9×
FY 2016 5y median 2.0× FY 2025
P/B 1.8×
FY 2016: 1.8×FY 2017: 0.3×FY 2018: 2.0×FY 2019: 3.1×FY 2020: 2.6×FY 2021: 2.3×FY 2022: 1.9×FY 2023: 1.3×FY 2024: 1.2×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
P/FCF 6.8×
FY 2016: -106×FY 2017: 1.8×FY 2018: 9.8×FY 2019: 23.4×FY 2020: -12.4×FY 2021: 31.2×FY 2022: 34.6×FY 2023: 7.9×FY 2024: 10.7×FY 2025: 6.8×
FY 2016 5y median 10.7× FY 2025
EV/EBITDA 8.1×
FY 2016: 5.0×FY 2017: 2.7×FY 2018: 10.2×FY 2019: 30.6×FY 2020: 23.2×FY 2021: 17.6×FY 2022: 16.7×FY 2023: 14.7×FY 2024: 7.8×FY 2025: 8.1×
FY 2016 5y median 14.7× FY 2025
EV/Sales 2.6×
FY 2016: 3.1×FY 2017: 2.0×FY 2018: 6.5×FY 2019: 11.1×FY 2020: 9.4×FY 2021: 7.5×FY 2022: 5.1×FY 2023: 3.0×FY 2024: 2.4×FY 2025: 2.6×
FY 2016 5y median 3.0× FY 2025
FCF Yield 14.6%
FY 2016: -0.9%FY 2017: 56.8%FY 2018: 10.2%FY 2019: 4.3%FY 2020: -8.1%FY 2021: 3.2%FY 2022: 2.9%FY 2023: 12.6%FY 2024: 9.3%FY 2025: 14.6%
FY 2016 5y median 9.3% FY 2025

Profitability

Gross Margin 42.5%
FY 2016: 100.2%FY 2017: 94.5%FY 2018: 95.8%FY 2019: 96.4%FY 2020: 93.5%FY 2021: 93.4%FY 2022: 91.9%FY 2023: 87.9%FY 2024: 84.1%FY 2025: 42.5%
FY 2016 5y median 87.9% FY 2025
Operating Margin -7.4%
FY 2016: -2.4%FY 2017: 31.0%FY 2018: 12.4%FY 2019: -8.5%FY 2020: -21.5%FY 2021: -10.5%FY 2022: -21.9%FY 2023: -16.4%FY 2024: -13.6%FY 2025: -7.4%
FY 2016 5y median -13.6% FY 2025
Net Margin -22.4%
FY 2016: -1.6%FY 2017: -8.1%FY 2018: -40.4%FY 2019: -36.1%FY 2020: -27.3%FY 2021: -21.9%FY 2022: -38.4%FY 2023: -43.6%FY 2024: -34.7%FY 2025: -22.4%
FY 2016 5y median -34.7% FY 2025
ROE -20.5%
FY 2016: -3.5%FY 2017: -3.4%FY 2018: -15.7%FY 2019: -11.0%FY 2020: -9.1%FY 2021: -8.2%FY 2022: -18.8%FY 2023: -28.2%FY 2024: -27.6%FY 2025: -20.5%
FY 2016 5y median -20.5% FY 2025
ROIC -3.5%
FY 2016: -4.2%FY 2017: 6.7%FY 2018: 2.5%FY 2019: -1.6%FY 2020: -4.1%FY 2021: -2.4%FY 2022: -6.0%FY 2023: -5.5%FY 2024: -5.4%FY 2025: -3.5%
FY 2016 5y median -5.4% FY 2025
ROA -9.2%
FY 2016: -3.4%FY 2017: -1.6%FY 2018: -8.1%FY 2019: -6.1%FY 2020: -5.0%FY 2021: -4.8%FY 2022: -9.8%FY 2023: -13.2%FY 2024: -12.3%FY 2025: -9.2%
FY 2016 5y median -9.8% FY 2025

Growth (YoY)

Revenue -0.3%
FY 2016: 167.5%FY 2017: 40.7%FY 2018: -18.2%FY 2019: -11.8%FY 2020: 3.6%FY 2021: 7.0%FY 2022: 2.4%FY 2023: 2.6%FY 2024: -10.2%FY 2025: -0.3%
FY 2016 FY 2025
Operating Income 45.6%
FY 2016: 49.1%FY 2017: 1954.1%FY 2018: -67.2%FY 2019: -160.6%FY 2020: -161.2%FY 2021: 48.0%FY 2022: -113.9%FY 2023: 23.0%FY 2024: 25.7%FY 2025: 45.6%
FY 2016 FY 2025
EPS (diluted) 35.5%
FY 2016: 63.9%FY 2017: -579.9%FY 2018: -283.3%FY 2019: 27.2%FY 2020: 28.4%FY 2021: 14.6%FY 2022: -78.0%FY 2023: -16.4%FY 2024: 27.1%FY 2025: 35.5%
FY 2016 FY 2025
Free Cash Flow 97.9%
FY 2016: 86.4%FY 2017: 6483.0%FY 2018: 18.4%FY 2019: -25.4%FY 2020: -248.2%FY 2021: 133.7%FY 2022: -43.0%FY 2023: 129.6%FY 2024: -48.8%FY 2025: 97.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 56.4×FY 2017: 1.9×FY 2018: 0.8×FY 2019: 1.3×FY 2020: 1.3×FY 2021: 1.6×FY 2022: 1.4×FY 2023: 1.7×FY 2024: 1.6×FY 2025: 1.1×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 0.8×
FY 2016: 53.7×FY 2017: 1.8×FY 2018: 0.8×FY 2019: 1.3×FY 2020: 1.0×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 1.2×FY 2025: 0.8×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.8×
FY 2016: 5.8×FY 2017: 0.8×FY 2018: 0.6×FY 2019: 0.5×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.8×FY 2023: 0.9×FY 2024: 0.9×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 2.1×
FY 2016: 3.6×FY 2017: 1.8×FY 2018: 2.2×FY 2019: 2.3×FY 2020: 3.8×FY 2021: 3.0×FY 2022: 4.1×FY 2023: 5.1×FY 2024: 2.8×FY 2025: 2.1×
FY 2016 5y median 3.0× FY 2025
Interest Coverage -0.6×
FY 2016: -0.1×FY 2017: 1.0×FY 2018: 0.4×FY 2019: -0.6×FY 2020: -1.9×FY 2021: -0.9×FY 2022: -1.8×FY 2023: -1.2×FY 2024: -0.8×FY 2025: -0.6×
FY 2016 5y median -0.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.3%FY 2019: 0.8%FY 2020: 1.1%FY 2021: 1.4%FY 2022: 2.0%FY 2023: 1.9%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 1.4% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -4.2%FY 2019: -22.7%FY 2020: -32.6%FY 2021: -38.7%FY 2022: -20.2%FY 2023: -8.7%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -8.7% FY 2025

Annual · latest fiscal year ends 2025-12-31